Related Experiment Video
Updated: Jul 2, 2026

Assays for the Degradation of Misfolded Proteins in Cells
Published on: August 28, 2016
Recognition of misfolded proteins by Lon, a AAA(+) protease
1Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Abstract:
Proteins unfold constantly in cells, especially under stress conditions. Degradation of denatured polypeptides by Lon and related ATP-dependent AAA(+) proteases helps prevent toxic aggregates formation and other deleterious consequences, but how these destructive enzymatic machines distinguish between damaged and properly folded proteins is poorly understood. Here, we show that Escherichia coli Lon recognizes specific sequences -- rich in aromatic residues -- that are accessible in unfolded polypeptides but hidden in most native structures. Denatured polypeptides lacking such sequences are poor substrates. Lon also unfolds and degrades stably folded proteins with accessible recognition tags. Thus, protein architecture and the positioning of appropriate targeting sequences allow Lon degradation to be dependent or independent of the folding status of a protein. Our results suggest that Lon can recognize multiple signals in unfolded polypeptides synergistically, resulting in nanomolar binding and a mechanism for discriminating irreversibly damaged proteins from transiently unfolded elements of structure.
Insights
The Lon protease recognizes specific aromatic-rich sequences in unfolded proteins, preventing toxic aggregate formation. This mechanism allows Lon (a AAA+ protease) to degrade damaged proteins while sparing most native structures.
Area of Science:
- Cellular Biology
- Protein Degradation
- Enzymology
Background:
- Cells constantly experience protein unfolding, particularly under stress.
- ATP-dependent proteases like Lon are crucial for degrading denatured proteins and preventing toxic aggregation.
- The precise mechanisms by which Lon distinguishes damaged from functional proteins remain unclear.
Purpose of the Study:
- To elucidate the substrate recognition mechanism of Escherichia coli Lon protease.
- To determine how Lon differentiates between unfolded and properly folded proteins.
Main Methods:
- Investigated substrate binding and degradation using denatured and native proteins with and without specific recognition sequences.
- Analyzed the role of aromatic residues in Lon recognition.
- Assessed the impact of protein architecture on Lon substrate preference.
Main Results:
- Escherichia coli Lon protease specifically recognizes sequences rich in aromatic residues, which are exposed in unfolded polypeptides but buried in native structures.
- Denatured proteins lacking these aromatic-rich sequences are poor Lon substrates.
- Lon can also unfold and degrade stably folded proteins if they possess accessible recognition tags.
- Multiple signals are recognized synergistically, leading to high-affinity binding (nanomolar) to unfolded proteins.
Conclusions:
- Lon protease utilizes specific sequence motifs, particularly those rich in aromatic residues, for substrate recognition.
- Protein architecture and the accessibility of these motifs dictate whether Lon degrades a protein independently of its folding status.
- This recognition mechanism provides a means to discriminate irreversibly damaged proteins from transiently unfolded structures, preventing cellular damage.
Related Concept Videos
Export of Misfolded Proteins out of the ER
The Unfolded Protein Response
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Molecular Chaperones and Protein Folding
The...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

